About US
Contact us
-
Lilly unwraps detailed data showing tirzepatide kept nearly 99% of prediabetic patients diabetes-free over 3 yearsFollowing an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based drugma2024/11/6
-
In boost to GSK's £3B plan for Blenrep, myeloma ADC shows survival edge over J&J's DarzalexGSK’s 3 billion pounds sterling peak sales goal for its multiple myeloma drug Blenrep appears increasingly attainable thanks to a key patient survival win. The antibody-drug conjugate (ADC) has mount2024/10/30
-
Activist investor Starboard sets its sights on J&J spinout Kenvue: WSJActivist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has Johnson & Johnson’s consumer health spinout Kenvue in its sights. The invest2024/9/24
-
Takeda details another round of layoffs in Massachusetts as restructuring drive rolls onFollowing a series of layoff rounds this year, Takeda is once again pruning its headcount in the Bay State. Takeda is laying off dozens of employees in Massachusetts, according to a Worker Adjustment2024/9/24
-
ICER raises cost-effective price for Pfizer's ATTR drug in final analysis but still calls for hefty discountAfter calling for a major discount for Pfizer’s popular transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis, a U.S. drug cost watchdog has provided a final analysis that includes a smaller—y2024/9/30
-
Sanofi in 'exclusive negotiations' to sell 50% stake in €16B consumer health unit OpellaSanofi is now in“exclusive negotiations”with U.S. private equity firm Clayton, Dubilier & Rice (CD&R) to sell a 50% controlling stake in its consumer health business Opella. With the French g2024/10/10
-
CDMO Samsung Biologics bags $1.2B production contract, bringing total 2024 deal value to $3.3B+With multiple high-profile production pacts already in the books for 2024, CDMO Samsung Biologics has hooked another big one. Samsung has locked down a $1.2 billion contract with an unnamed Asia-base2024/10/10
-
DOJ challenges Johnson & Johnson's talc bankruptcy attempt in TexasWith Johnson & Johnson sweetening the pot and mustering up the support of 83% of those who claim that the company’s talc products caused their cancer, it hadappearedthat the sides were speeding t2024/10/15
-
Pfizer lays off 75 more workers in North Carolina in wake of late-stage DMD trial failPfizer has told 75 employees in Sanford, North Carolina, that their positions have been eliminated. The layoffs come three months after the company axed 150 positions in Sanford following a high-prof2024/10/15
-
Amid geopolitical tensions, Legend sheds Genscript as its majority shareholderLegend Biotech has managed to remove Genscript Biotech as its majority shareholder, just as the former parent’s Chinese background falls under a U.S. biosecurity microscope. After a financial maneuve2024/10/17